Matuzumab Biosimilar - Research Grade
Bulk Matuzumab Biosimilar - Research Grade
Product Specific Citations:
Tikum et al. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics (2022).
Bulk Matuzumab Biosimilar - Research Grade
Product Specific Citations:
Tikum et al. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics (2022).
Product Benefits:
ichorbio's matuzumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility.
Size:
ichorbio's research grade matuzumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our matuzumab biosimilar - please contact us for pricing.
Target:
EGFR
Clone:
n/a
Isotype:
IgG1 kappa
Other Names:
Host:
Humanized
Species Reactivity:
Human
Specificity:
Detects human EGFR.
Purification Method:
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:
Matuzumab biosimilar is a humanized IgG1 monoclonal antibody against human EGFR. As it only has approximately 10% murine origin it has limited immunogenicity, and being IgG1 it is capable of inducing antibody dependent cell cytotoxicity (ADCC).Matuzumab biosimilar is produced in mammalian (Chinese hamster ovary) cell culture.
Concentration:
1.0 - 5.0 mg/ml
Formulation:
Sterile, clear, colorless, preservative-free solution with a pH of about 7.2, containing dihydrate Disodium hydrogen phosphate, sodium dihydrogen phosphate monohydrate, polysorbate 80, and sucrose.
Purity:
>95% by SDS-PAGE and HPLC
Endotoxin:
≤ 0.75 EU/mg as determined by the LAL method
Storage:
Matuzumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:
Functional Assays
Application Notes:
Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's matuzumab biosimilar is for research use only. Isotype Control:
| Concentration | 14.66mg/ml |
|---|---|
| Isotype | IgG1 kappa |
| Host | Humanized |
| citation | Bulk Matuzumab Biosimilar - Research GradeProduct Specific Citations: Tikum et al. Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates. Pharmaceutics (2022).
|
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Matuzumab. |
| Species Reactivity | Human |
| Target | EGFR |
| Shipping Conditions | Blue ice |
| background | Matuzumab biosimilar is a humanized IgG1 monoclonal antibody against human EGFR. As it only has approximately 10% murine origin it has limited immunogenicity, and being IgG1 it is capable of inducing antibody dependent cell cytotoxicity (ADCC).Matuzumab b |
| Other names | Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1 |
| UniProt | P00533 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |